Prestige BioPharma (XKRX:950210) Short-Term Debt : ₩67,213 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Prestige BioPharma Short-Term Debt?

Prestige BioPharma's Short-Term Debt for the quarter that ended in Sep. 2024 was ₩67,213 Mil.

Prestige BioPharma's quarterly Short-Term Debt increased from Mar. 2024 (₩43,403 Mil) to Jun. 2024 (₩47,845 Mil) and increased from Jun. 2024 (₩47,845 Mil) to Sep. 2024 (₩67,213 Mil).

Prestige BioPharma's annual Short-Term Debt increased from Jun. 2022 (₩0 Mil) to Jun. 2023 (₩31,176 Mil) and increased from Jun. 2023 (₩31,176 Mil) to Jun. 2024 (₩47,845 Mil).

Prestige BioPharma Short-Term Debt Historical Data

The historical data trend for Prestige BioPharma's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige BioPharma Short-Term Debt Chart

Prestige BioPharma Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Jun24

Short-Term Debt

2,873.03

31,175.51

47,844.86

Prestige BioPharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial														35,533.12	39,299.27	43,403.06	47,844.86	67,213.43

Prestige BioPharma Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Prestige BioPharma Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Prestige BioPharma's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prestige BioPharma Ltd (XKRX:950210) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Science Park Drive No. 04-13/14, Ascent Tower B, Singapore Science Park, Singapore, SGP, 118222

Website

https://www.prestigebiopharma.com

Prestige BioPharma Ltd is a biopharmaceutical company. The company is focused on the development of biosimilars and new antibody therapeutics. It focuses on oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis.

Prestige BioPharma Headlines

No Headlines